Alembic logo

Alembic MD, chairman, board of directors and AGM

NSE: ALEMBICLTDBSE: 506235RealtySmall Cap

Formerly Alembic Chemical Works Co.
Last close ₹86.73down ₹3.55 (3.93%)BSE ₹86.85

Share price at the NSE close on 23 Oct 2026. Previous close ₹90.28.

52-week range of traded prices to 23 Oct 2026
₹70.46Low, 30 Mar 2026₹117.72High, 3 Sep 2026
Market cap
₹2,227 Cr1,101st largest listed
P/E
6.9
P/B
0.9
Dividend yield
2.77%
ROE
13.4%
ROCE
3.0%
Debt to equity
0.00
Volume, NSE
6,29,66348.5% delivered

Alembic board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonChirayu Ramanbhai AminRelated to the promoter
  • Managing directorUdit Chirayu Amin
  • Company Secretary and Compliance OfficerKeval Thakkar

8 directors4 independent1 executive3 non-executive

  • Chirayu Ramanbhai Amin · ChairpersonNon-executive · joined Aug 1967 · reappointed Mar 2011 · 3 listed boards
  • Malika Chirayu AminNon-executive · joined Jul 1988 · reappointed Jan 2026 · 1 listed board
  • Udit Chirayu Amin · Managing directorExecutive · joined Apr 2013 · reappointed Oct 2025 · 2 listed boards · 1 committee seat
  • Rati Ajay DesaiIndependent · joined Aug 2019 · reappointed Aug 2024 · 85 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Girish Srinivasiah HirodeIndependent · joined Aug 2023 · reappointed Aug 2023 · 37 months as independent · 1 listed board · 1 as independent
  • Mayurdhvaj Dilipsinh JadejaIndependent · joined Feb 2025 · reappointed Feb 2025 · 19 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • Sanjeev Virendra ShahIndependent · joined Feb 2025 · reappointed Feb 2025 · 19 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • Jain ParkashNon-executive · joined Feb 2025 · reappointed Feb 2025 · 2 listed boards · 1 committee seat

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

3 directors who left
  • Sameer Subhash Khera, left 24 Feb 2025: Tenure Completion
  • Abhijit Achyut Joshi, left 7 Feb 2025: Others
  • Mayank Natubhai Amin, left 16 Jan 2025: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 11 Aug 20268 of 8 present4 independent · 83 days in between
    • 19 May 20268 of 8 present4 independent

  • Audit Committee

    Chair Rati Ajay Desai

    Mayurdhvaj Dilipsinh Jadeja, Sanjeev Virendra Shah

    • 11 Aug 20263 of 3 present3 independent · 83 days in between
    • 19 May 20263 of 3 present3 independent

  • Nomination and remuneration committee

    Chair Rati Ajay Desai

    Girish Srinivasiah Hirode, Mayurdhvaj Dilipsinh Jadeja, Sanjeev Virendra Shah

    • 19 May 20263 of 4 present3 independent

  • Stakeholders Relationship Committee

    Chair Mayurdhvaj Dilipsinh Jadeja

    Udit Chirayu Amin, Sanjeev Virendra Shah

    • 11 Aug 20263 of 3 present2 independent · 83 days in between
    • 19 May 20262 of 3 present1 independent

  • Risk Management Committee

    Chair Rati Ajay Desai

    Jain Parkash, Avaneeshnath Sharma

    • 11 Aug 20262 of 2 present1 independent

  • Corporate Social Responsibility Committee

    Chair Malika Chirayu Amin

    Mayurdhvaj Dilipsinh Jadeja, Rati Ajay Desai

    • 11 Aug 20263 of 3 present2 independent · 83 days in between
    • 19 May 20263 of 3 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • CNK & Associates LLPPeer-review certificate valid to Jul 2027
1 earlier auditor
  • M/s. CNK & Associates LLPNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Alembic AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Alembic dividend history

Annual general meeting, 11 Aug 2026

1,03,085 shareholders on the register on 4 Aug 2026; present: 28 promoters and 48 others; votes counted by Mr. S. Samdani / M/s. Samdani Shah & Kabra.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2026 together with the Reports of the Board of Directors and the Auditors thereon. b. the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026 together with the Report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 74.20% · promoters 100.00% · institutions 64.48% · other public 8.87%

  2. To declare dividend on equity shares for the financial year 2025-26.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.09%

    Turnout: all 74.23% · promoters 100.00% · institutions 66.66% · other public 8.87%

  3. To appoint a Director in place of Mrs. Malika Amin (DIN: 00242613), who retires by rotation and being eligible, offers herself for re-appointment.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.20%

    Turnout: all 74.23% · promoters 100.00% · institutions 66.66% · other public 8.87%

  4. Payment of commission to Mr. Udit Amin (DIN: 00244235) for the period upto 30th September, 2025, as Non-Executive Director of the Company.
    Special
    98.80% for1.20% against

    Against: promoters 0.00% · institutions 99.95% · other public 0.27%

    Turnout: all 74.23% · promoters 100.00% · institutions 66.66% · other public 8.87%

  5. Ratification of Remuneration to the Cost Auditors for the financial year 2026-27.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.18%

    Turnout: all 74.23% · promoters 100.00% · institutions 66.66% · other public 8.87%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 19 Sep 2025, 1 resolution

1,09,467 shareholders on the register on 14 Aug 2025; votes counted by Mr. S. Samdani / M/s. Samdani Shah & Kabra.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Udit Amin (DIN: 00244235) as Managing Director of the Company.
    Special
    98.90% for1.10% against

    Against: promoters 0.00% · institutions 99.53% · other public 0.60%

    Turnout: all 74.76% · promoters 100.00% · institutions 55.11% · other public 11.12%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 12 Aug 2025, 6 resolutions

1,09,653 shareholders on the register on 5 Aug 2025; present: 31 promoters and 47 others; votes counted by Mr. S. Samdani / M/s. Samdani Shah & Kabra.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2025 together with the Reports of the Board of Directors and the Auditors thereon. b. the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2025 together with the Report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 74.25% · promoters 100.00% · institutions 53.45% · other public 9.30%

  2. To declare dividend on equity shares for the financial year 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 74.28% · promoters 100.00% · institutions 55.38% · other public 9.30%

  3. To appoint a Director in place of Mr. Chirayu Amin (DIN: 00242549), who retires by rotation and being eligible, offers himself for re-appointment.
    SpecialPromoters have an interest in it
    99.91% for0.09% against

    Against: promoters 0.00% · institutions 1.42% · other public 2.12%

    Turnout: all 74.28% · promoters 100.00% · institutions 55.38% · other public 9.30%

  4. Payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2024-25.
    Special
    98.81% for1.19% against

    Against: promoters 0.00% · institutions 100.00% · other public 2.13%

    Turnout: all 74.28% · promoters 100.00% · institutions 55.38% · other public 9.30%

  5. Appointment of Secretarial Auditors of the Company and to fix their remuneration.
    Ordinary
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.06%

    Turnout: all 74.28% · promoters 100.00% · institutions 55.38% · other public 9.30%

  6. Ratification of Remuneration to the Cost Auditors for the financial year 2025-26.
    Ordinary
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.06%

    Turnout: all 74.28% · promoters 100.00% · institutions 55.38% · other public 9.30%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 22 Mar 2025, 3 resolutions

1,09,036 shareholders on the register on 14 Feb 2025; votes counted by Mr. S. Samdani / M/s. Samdani Shah & Kabra.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Mayurdhvaj Jadeja (DIN: 00799518) as an Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 74.67% · promoters 100.00% · institutions 58.61% · other public 10.00%

  2. Appointment of Mr. Sanjeev Shah (DIN: 00106702) as an Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 74.67% · promoters 100.00% · institutions 58.61% · other public 10.00%

  3. Appointment of Mr. Jain Parkash (DIN: 10922687) as Non-Executive Non-Independent Director of the Company.
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 5.20% · other public 0.08%

    Turnout: all 74.67% · promoters 100.00% · institutions 58.61% · other public 10.00%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 12 Aug 2024, 5 resolutions

Present: 26 promoters and 57 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt:na. the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2024 together with the Reports of the Board of Directors and the Auditors thereon.nb. the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2024 together with the Report of the Auditors thereon.MoreLess
    Ordinary
    99.00% for1.00% against

    Against: promoters 0.00% · institutions 96.76% · other public 0.08%

    Turnout: all 74.19% · promoters 100.00% · institutions 38.66% · other public 9.37%

  2. To declare dividend on equity shares for the financial year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.11%

    Turnout: all 74.22% · promoters 100.00% · institutions 40.12% · other public 9.37%

  3. To appoint a Director in place of Mr. Udit Amin (DIN: 00244235), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 9.62% · other public 0.12%

    Turnout: all 74.22% · promoters 100.00% · institutions 40.12% · other public 9.37%

  4. Payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2023-24.
    Special
    98.92% for1.08% against

    Against: promoters 0.00% · institutions 100.00% · other public 0.24%

    Turnout: all 74.22% · promoters 100.00% · institutions 40.12% · other public 9.37%

  5. Ratification of Remuneration to the Cost Auditors for the financial year 2024-25.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 74.22% · promoters 100.00% · institutions 40.12% · other public 9.37%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 25 Jun 2024, 2 resolutions

The company's voting result (opens in a new tab)

  1. Approval of material related party transactions with Shreno Limited.
    OrdinaryPromoters have an interest in it
    99.08% for0.92% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.18%

    Turnout: all 3.13% · promoters 0.00% · institutions 57.20% · other public 8.76%

  2. Re-appointment of Mrs. Rati Desai (DIN: 08535681) as an Independent Director of the Company.
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.45%

    Turnout: all 75.52% · promoters 100.00% · institutions 57.20% · other public 14.18%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 10 Aug 2023, 9 resolutions

Present: 28 promoters and 44 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2023 and the Reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    94.31% for5.69% against

    Against: promoters 0.00% · institutions 99.79% · other public 0.08%

    Turnout: all 77.82% · promoters 100.00% · institutions 94.07% · other public 10.24%

  2. To declare dividend on Equity Shares for the financial year 2022-23.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 77.84% · promoters 100.00% · institutions 94.69% · other public 10.24%

  3. To appoint a Director in place of Mr. Abhijit Joshi (DIN: 06568584), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.30% for0.70% against

    Against: promoters 0.00% · institutions 12.20% · other public 0.09%

    Turnout: all 77.84% · promoters 100.00% · institutions 94.69% · other public 10.24%

  4. To appoint Dr. Girish Hirode (DIN:10145777) as an Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.09%

    Turnout: all 77.84% · promoters 100.00% · institutions 94.69% · other public 10.24%

  5. To re-appoint Mr. Mayank Amin (DIN:03455164) as an Independent Director of the Company.
    Special
    99.28% for0.72% against

    Against: promoters 0.00% · institutions 12.55% · other public 0.09%

    Turnout: all 77.84% · promoters 100.00% · institutions 94.69% · other public 10.24%

  6. To consider approval of material related party transactions with Shreno Limited.
    OrdinaryPromoters have an interest in it
    89.79% for10.21% against

    Against: promoters 0.00% · institutions 12.41% · other public 0.22%

    Turnout: all 5.45% · promoters 0.00% · institutions 94.69% · other public 4.03%

  7. To consider approval of material related party transactions with Alembic Pharmaceuticals Limited.
    OrdinaryPromoters have an interest in it
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.22%

    Turnout: all 5.45% · promoters 0.00% · institutions 94.69% · other public 4.03%

  8. To consider payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2022-23.
    Special
    99.27% for0.73% against

    Against: promoters 0.00% · institutions 12.76% · other public 0.11%

    Turnout: all 77.84% · promoters 100.00% · institutions 94.69% · other public 10.24%

  9. Ratification of the Remuneration to the Cost Auditors for the financial year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.09%

    Turnout: all 77.84% · promoters 100.00% · institutions 94.69% · other public 10.24%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 20 Sep 2022, 8 resolutions

Present: 23 promoters and 52 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2022 and the reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 78.03% · promoters 100.00% · institutions 94.19% · other public 9.09%

  2. To declare dividend on Equity Shares for the financial year 2021-22.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 78.06% · promoters 100.00% · institutions 94.73% · other public 9.09%

  3. To appoint a Director in place of Mr. Chirayu Amin (DIN: 00242549), who retires by rotation and being eligible, offers himself for re-appointment.
    Special
    99.10% for0.90% against

    Against: promoters 0.00% · institutions 13.97% · other public 0.01%

    Turnout: all 78.06% · promoters 100.00% · institutions 94.73% · other public 9.09%

  4. To consider re-appointment of Statutory Auditors of the Company and to fix their remuneration.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 78.06% · promoters 100.00% · institutions 94.73% · other public 9.09%

  5. To consider approval of material related party transactions with Shreno Limited.
    OrdinaryPromoters have an interest in it
    87.73% for12.27% against

    Against: promoters 0.00% · institutions 13.90% · other public 0.05%

    Turnout: all 5.67% · promoters 0.00% · institutions 94.73% · other public 2.79%

  6. To consider approval of material related party transactions with Alembic Pharmaceuticals Limited.
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 5.67% · promoters 0.00% · institutions 94.73% · other public 2.79%

  7. To consider payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2021-22.
    Special
    99.10% for0.90% against

    Against: promoters 0.00% · institutions 13.97% · other public 0.05%

    Turnout: all 78.06% · promoters 100.00% · institutions 94.73% · other public 9.09%

  8. To consider payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for a period of 5 years commencing from financial year 2022-23.
    Special
    99.10% for0.90% against

    Against: promoters 0.00% · institutions 13.97% · other public 0.06%

    Turnout: all 78.06% · promoters 100.00% · institutions 94.73% · other public 9.09%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 19 Sep 2025, 1 fund house

  • Appointment of Mr. Udit Amin (DIN: 00244235) as Managing Director of the Company.
    1 for0 against

Mutual fund votes, meeting of 12 Aug 2025, 1 fund house

  • To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2025 together with the Reports of the Board of Directors and the Auditors thereon. b. the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2025 together with the Report of the Auditors thereon.MoreLess
    1 for0 against
  • To declare dividend on equity shares for the financial year 2024-25.
    1 for0 against
  • To appoint a Director in place of Mr. Chirayu Amin (DIN: 00242549), who retires by rotation and being eligible, offers himself for re-appointment.
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: Chairman related to Managing director.
    0 for1 against
  • Payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2024-25.
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: Excessive remuneration.
    0 for1 against
  • Appointment of Secretarial Auditors of the Company and to fix their remuneration.
    1 for0 against
  • Ratification of Remuneration to the Cost Auditors for the financial year 2025-26.
    1 for0 against
2 earlier meetings

Mutual fund votes, meeting of 10 Aug 2023, 1 fund house

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2023 and the Reports of the Board of Directors and Auditors thereon.MoreLess
    Against SBI Mutual Fund
    • SBI Mutual FundWe have relied upon the auditors’ report, which has issued a qualified opinion on the consolidated financial statements. The qualification pertains to the qualified opinion issued by the auditors of Alembic Pharmaceuticals Limited (APL), an associate of Alembic Limited. Alembic Limited holds 28.54% equity stake in APL as on 30 June 2023. The auditors of APL have issued a qualified opinion on standalone and consolidated financial statements as the company has withdrawn Rs. Rs. 10.26 bn from general reserve and transferred the same to statement of profit and loss as an ‘exceptional item’. The said treatment, in the auditor’s opinion, does not meet the criteria of ‘income’ under the Indian Accounting Standards and had the said treatment not been done, the PAT would have reduced by Rs. 10.26 bn, general reserve would have increased by Rs. 10.26 bn and EPS would have reduced by Rs. 52.18 on a standalone and consolidated basis. The auditors of APL have also raised an emphasis on transfer of Rs. 8.69 bn from general reserve to other equity pending approval from regulatory authorities. The auditors of Alembic Limited have also raised an emphasis on the status of liability pending electricity duty matters.
    0 for1 against
  • To declare dividend on Equity Shares for the financial year 2022-23.
    1 for0 against
  • To appoint a Director in place of Mr. Abhijit Joshi (DIN: 06568584), who retires by rotation and being eligible, offers himself for re-appointment.
    1 for0 against
  • To appoint Dr. Girish Hirode (DIN:10145777) as an Independent Director of the Company.
    1 for0 against
  • To re-appoint Mr. Mayank Amin (DIN:03455164) as an Independent Director of the Company.
    1 for0 against
  • To consider approval of material related party transactions with Shreno Limited.
    1 for0 against
  • To consider approval of material related party transactions with Alembic Pharmaceuticals Limited.
    1 for0 against
  • To consider payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2022-23.
    1 for0 against
  • Ratification of the Remuneration to the Cost Auditors for the financial year 2023-24.
    1 for0 against

Mutual fund votes, meeting of 20 Sep 2022, 3 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2022 and the reports of the Board of Directors and Auditors thereon.MoreLess
    3 for0 against
  • To declare dividend on Equity Shares for the financial year 2021-22.
    3 for0 against
  • To appoint a Director in place of Mr. Chirayu Amin (DIN: 00242549), who retires by rotation and being eligible, offers himself for re-appointment.
    3 for0 against
  • To consider re-appointment of Statutory Auditors of the Company and to fix their remuneration.
    3 for0 against
  • To consider approval of material related party transactions with Shreno Limited.
    3 for0 against
  • To consider approval of material related party transactions with Alembic Pharmaceuticals Limited.
    3 for0 against
  • To consider payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2021-22.
    2 for0 against
  • To consider payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for a period of 5 years commencing from financial year 2022-23.
    2 for0 against
2 proposals not matched to one resolution
  • 7) Approve payment of commission of Rs. 19.2 mn to Udit Amin, Non-Executive Director for FY22, in excess of 50% of the total remuneration payable to all non-executive directors.
    1 for0 against
  • 8) Approve payment of commission to Udit Amin, Non-Executive Director, upto 3% of net profits, for five years from FY23.
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Sep 2026.

  • Tax disputeThe Principal Commissioner, Central GST and Central Excise Vadodara ISince 10 Jan 2020
    The matter is pending with Hon'ble Supreme Court. There is no change in the status of the litigation from the last disclosure made dated 11th August, 2023.
    At the filing before: The Central GST and Central Excise Department is in appeal at Hon'ble Supreme Court considering sale of immovable property after receipt of completion certificate as exempted service (for one of the Company's residential project), against the orders which are ruled in the favour of the Company by the CESTAT and the Hon'ble Gujarat High Court.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.